Veracyte financials
$46.08+1.88%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $150.3M | $139.1M | $140.6M | $131.9M | $130.2M | $114.5M | $118.6M | $115.9M | $114.4M | $93.9M | $98.2M | $90.1M |
| Gross profit | $108.5M | $101.2M | $102.0M | $91.3M | $89.8M | $79.5M | $78.8M | $79.0M | $77.9M | $62.5M | $64.8M | $57.7M |
| Gross margin | 72.2% | 72.7% | 72.5% | 69.2% | 69.0% | 69.5% | 66.4% | 68.2% | 68.1% | 66.5% | 66.0% | 64.0% |
| Operating income | $23.0M | $22.6M | $37.2M | $22.9M | -$5.3M | $2.9M | $4.2M | $12.0M | $4.6M | -$4.7M | -$35.5M | -$31.7M |
| Net income | $25.5M | $28.7M | $41.1M | $19.1M | -$980.0K | $7.0M | $5.1M | $15.2M | $5.7M | -$1.9M | -$28.3M | -$29.6M |
| Net margin | 17.0% | 20.6% | 29.3% | 14.5% | −0.8% | 6.2% | 4.3% | 13.1% | 5.0% | −2.0% | −28.8% | −32.9% |
| Diluted EPS | $0.31 | $0.35 | $0.49 | $0.24 | $-0.01 | $0.09 | $0.06 | $0.19 | $0.07 | $-0.02 | $-0.39 | $-0.41 |
| EBITDA | $27.8M | $28.1M | $42.5M | $28.2M | $20.7M | $8.3M | $13.2M | $18.1M | $10.3M | $1.4M | -$3.5M | $10.5M |
| Operating cash flow | $45.8M | $35.2M | $52.6M | $44.8M | $33.6M | $5.4M | $24.5M | $30.0M | $29.6M | -$9.0M | $20.9M | $13.8M |
| Free cash flow | $43.0M | $32.3M | $48.8M | $42.0M | $32.3M | $3.5M | $20.4M | $27.7M | $26.8M | -$11.1M | $18.4M | $11.0M |
| Diluted shares | 82.1M | 81.3M | 84.2M | 79.7M | 78.4M | 80.1M | 82.3M | 78.5M | 77.2M | 74.8M | 73.1M | 72.8M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $299.5M | $263.1M | $362.6M | $315.6M | $219.5M | $186.1M |
| Short-term investments | $185.7M | $175.9M | $50.3M | $50.9M | $101.2M | $101.2M |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $1.49B | $1.44B | $1.41B | $1.37B | $1.34B | $1.32B |
| Total liabilities | $98.0M | $92.0M | $96.4M | $110.1M | $123.0M | $120.5M |
| Shareholders' equity | $1.39B | $1.34B | $1.31B | $1.26B | $1.22B | $1.19B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology